⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.81
−0.59%
Brent
$109.22
−0.54%
BTC
$82,070.00
+0.07%
ETH
$2,404.50
−0.12%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,140.81
−0.59%
Brent
$109.22
−0.54%
BTC
$82,070.00
+0.07%
ETH
$2,404.50
−0.12%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
ImmunityBio Inc · News · TradingHolo
Markets
›
United States
› NAS
› IBRX
I
ImmunityBio Inc
NAS:IBRX
Healthcare
CBOEFTSE:MRUT
NASDAQ:NBI
$8.42
−8.28%
At close
At close · Tue 20 Oct · ≈
AED 30.92
· Market cap
$8.92B
· Next earnings
Tue 3 Nov
· Extended
$8.45
+0.36%
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
IBRX news
Headlines tagged to this company
BU
ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors
BusinessWire · 3 d ago
TR
ImmunityBio, Inc. (IBRX) Posts 3-Year Data: 84% Cystectomy Avoidance
TradingView · 3 d ago
DO
ImmunityBio Price Target Raised to $14.00/Share From $12.00 by Jefferies
Dow Jones Newswires · 4 d ago
DO
ImmunityBio Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones Newswires · 4 d ago
TR
HC Wainwright & Co. reiterates Buy rating on ImmunityBio, $15 price target
TradingView · 4 d ago
ST
IBRX Stock Eyes Weekly Slump Despite Anktiva FDA Win — Retail Stays Cautious Ahead Of Founder’s Trial Talk
Stocktwits · 5 d ago
TR
ImmunityBio: FDA expands ANKTIVA approval to include papillary-only BCG-unresponsive NMIBC
TradingView · 5 d ago
RE
FDA Expands Anktiva® Approval For Bcg-Unresponsive Non-Muscle-Invasive Bladder Cancer To Cover Both Papillary And Cis Disease
Reuters · 5 d ago
DO
FDA Expands Indication for ImmunityBio's Bladder Cancer Drug
Dow Jones Newswires · 5 d ago
TR
ImmunityBio, Inc. (IBRX) Wins FDA Label Expansion for ANKTIVA in Papillary-Only BCG-Unresponsive NMIBC
TradingView · 5 d ago
ST
IBRX Stock Rallies After FDA Clears Broader Anktiva Use In Bladder Cancer Months Ahead Of Deadline
Stocktwits · 5 d ago
SE
ImmunityBio's Anktiva gains expanded bladder cancer approval
Seeking Alpha · 5 d ago
RE
US FDA Approves Nogapendekin Alfa Inbakicept-Pmln For BCG-Unresponsive NMIBC On Oct 14, 2026
Reuters · 5 d ago
ST
SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals
Stocktwits · 6 d ago
BU
ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium
BusinessWire · 11 d ago
ST
IBRX Stock Under Pressure: Retail Sees 'Ridiculously Cheap' Bargain As Founder Touts Sister Firm NantIQ's Aetna Work
Stocktwits · 12 d ago
ST
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
Stocktwits · 14 d ago
ST
IBRX Stock Logs Best Week In Over 7 Months: Retail Eyes Anktiva Boost From Trump’s Cancer Panel Pick
Stocktwits · 15 d ago
More news →